Vitamin-K-antagonist phenprocoumon versus low-dose direct oral anticoagulants (DOACs) in patients with atrial fibrillation: a real-world analysis of German claims data
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Thrombosis Journal 20 (2022): 31.
- Event
-
Veröffentlichung
- (where)
-
Erlangen
- (who)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (when)
-
2022
- Creator
-
Warkentin, Lisette
Hueber, Susann
Deiters, Barthold
Klohn, Florian
Kühlein, Thomas
- DOI
-
10.1186/s12959-022-00389-9
- URN
-
urn:nbn:de:bvb:29-opus4-215959
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Warkentin, Lisette
- Hueber, Susann
- Deiters, Barthold
- Klohn, Florian
- Kühlein, Thomas
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Time of origin
- 2022
Other Objects (12)
Vitamin-K-antagonist phenprocoumon versus low-dose direct oral anticoagulants (DOACs) in patients with atrial fibrillation: a real-world analysis of German claims data
Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillation
Comparison of the efficacy and risk of therapy with the vitamin K antagonist Phenprocoumon with new oral anticoagulants in catheter ablation of atrial fibrillation
Underutilization of anticoagulants in patients with nonvalvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants
Coagulation testing in intracerebral hemorrhage related to non-vitamin K antagonist oral anticoagulants
Inappropriate non-vitamin K antagonist oral anticoagulants prescriptions: be cautious with dose reductions
Non-vitamin K antagonist oral anticoagulants in patients with an increased risk of bleeding
Drug interaction: Omeprazole and Phenprocoumon
Rivaroxaban and other non-vitamin K antagonist oral anticoagulants in the emergency treatment of thromboembolism
Non-vitamin-K-antagonist oral anticoagulants (NOACs) after acute myocardial infarction: a network meta-analysis
Nonvitamin K Antagonist Oral Anticoagulants in Patients with Extreme Body Weights: One Size Fits All?
Prediction of phenprocoumon maintenance dose and phenprocoumon plasma concentration by genetic and non-genetic parameters
Vitamin-K-antagonist phenprocoumon versus low-dose direct oral anticoagulants (DOACs) in patients with atrial fibrillation: a real-world analysis of German claims data
Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillation
Comparison of the efficacy and risk of therapy with the vitamin K antagonist Phenprocoumon with new oral anticoagulants in catheter ablation of atrial fibrillation
Underutilization of anticoagulants in patients with nonvalvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants
Coagulation testing in intracerebral hemorrhage related to non-vitamin K antagonist oral anticoagulants
Inappropriate non-vitamin K antagonist oral anticoagulants prescriptions: be cautious with dose reductions
Non-vitamin K antagonist oral anticoagulants in patients with an increased risk of bleeding
Drug interaction: Omeprazole and Phenprocoumon
Rivaroxaban and other non-vitamin K antagonist oral anticoagulants in the emergency treatment of thromboembolism
Non-vitamin-K-antagonist oral anticoagulants (NOACs) after acute myocardial infarction: a network meta-analysis
Nonvitamin K Antagonist Oral Anticoagulants in Patients with Extreme Body Weights: One Size Fits All?
Prediction of phenprocoumon maintenance dose and phenprocoumon plasma concentration by genetic and non-genetic parameters
Vitamin-K-antagonist phenprocoumon versus low-dose direct oral anticoagulants (DOACs) in patients with atrial fibrillation: a real-world analysis of German claims data
Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillation
Comparison of the efficacy and risk of therapy with the vitamin K antagonist Phenprocoumon with new oral anticoagulants in catheter ablation of atrial fibrillation
Underutilization of anticoagulants in patients with nonvalvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants
Coagulation testing in intracerebral hemorrhage related to non-vitamin K antagonist oral anticoagulants
Inappropriate non-vitamin K antagonist oral anticoagulants prescriptions: be cautious with dose reductions
Non-vitamin K antagonist oral anticoagulants in patients with an increased risk of bleeding
Drug interaction: Omeprazole and Phenprocoumon
Rivaroxaban and other non-vitamin K antagonist oral anticoagulants in the emergency treatment of thromboembolism
Non-vitamin-K-antagonist oral anticoagulants (NOACs) after acute myocardial infarction: a network meta-analysis
Nonvitamin K Antagonist Oral Anticoagulants in Patients with Extreme Body Weights: One Size Fits All?